5 min readNew DelhiJun 8, 2026 07:00 PM IST<\/p>\n
The Big Bang Theory\u2019s Mayim Bialik has opened up about a severe reaction she experienced after taking a shot of the lowest dose of a synthetic GLP-1. In a personal essay, Bialik revealed that a single injection triggered weeks of debilitating gastrointestinal symptoms, including diarrhoea, cramping, bloating, nausea, and dehydration. She said she was prescribed the drug not primarily for weight loss, but because doctors believed it might help ease inflammation linked to her autoimmune condition, Graves\u2019 disease.<\/p>\n
\u201cGLP-1s have helped people in serious need. Of that I am certain. But nobody talks much about what happens when it goes wrong. I took one shot of the lowest dose of a synthetic GLP-1, and to say I had an adverse reaction would be somewhat of an understatement. Explosive, uncontrollable diarrhea. Sulfur burps so violent they left me afraid to open my mouth in public. Sneezing attacks every time I tried to eat or drink\u2014which apparently has a name,\u00a0snatiation. Cramping. Bloating. Full-body aching, as though I had the flu. And an inability to keep down even small sips of water without sprinting to the bathroom with yet more explosive diarrhea. More than three times, I didn\u2019t make it,\u201d she wrote in The Free Press.<\/p>\n
<\/p>\n
Her account has raised concern around the safety profile of GLP-1 medications, their expanding use beyond weight management, and how patients can distinguish expected side effects from potentially serious adverse reactions.<\/p>\n
DISCLAIMER: This article is based on information from the public domain and\/or the experts we spoke to. Always consult your health practitioner before starting any routine.<\/p>\n
How common are severe reactions to GLP-1 drugs?<\/p>\n
GLP-1 receptor agonists, including semaglutide and tirzepatide, have become increasingly popular for managing obesity and type 2 diabetes. While gastrointestinal side effects are well recognised, experts say reactions as severe as the one described by Bialik are uncommon. \u201cMany users experience mild to moderate nausea, diarrhoea, vomiting, abdominal discomfort, or constipation, particularly when starting treatment or increasing the dose,\u201d explains Dr Sandeep Kharb, Senior Consultant \u2013 Endocrinology, Asian Hospital. \u201cHowever, the kind of serious response described by Mayim Bialik, involving explosive diarrhoea, inability to keep fluids down, and dehydration requiring medical attention, is much less common.\u201d<\/p>\n
![\"\"](\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/06\/track_1x1.jpg\"){kind=spacer}
<\/p>\n